SCRC Partner Profile: A Textbook Transformation at Biogen-Idec
Supply Chain View from the Field
AUGUST 8, 2013
In addition, much of the power in decision-making lies in the hands of clinical trials scientists, who often have power over procurement decisions. The company discovers, develops, manufactures, and markets biological products for treating conditions such as multiple sclerosis and non-Hodgkin’s lymphoma. It was formed from the November 2003 merger of Biogen, Inc.